Beta antagonists primarily target which receptors?

Beta antagonists primarily target beta-1 receptors, which are predominantly found in the heart and play a crucial role in regulating cardiac function. By blocking these receptors, beta antagonists reduce heart rate, decrease myocardial contractility, and lower blood pressure, making them effective in managing conditions such as hypertension, angina, and heart failure.

In the context of pharmacology, beta-1 receptors are a significant focus for therapies aimed at cardiovascular issues, as their blockade directly counters the effects of sympathetic nervous system activation on the heart. This is why beta antagonists are specifically designed to interact with these receptors, offering therapeutic benefits in various cardiovascular conditions.